Propanc Biopharma, Inc.
PPCB
$1.87
-$0.08-4.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.80K | 14.60K | 9.30K | 21.10K | 6.20K |
| Total Receivables | 3.60K | 2.00K | 3.30K | 3.00K | 5.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.68M | 1.40K | 9.00K | 1.40K | 1.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.30K | -- | -- | -- | -- |
| Total Current Assets | 9.74M | 18.00K | 21.50K | 25.40K | 12.90K |
|
|
|||||
| Total Current Assets | 9.74M | 18.00K | 21.50K | 25.40K | 12.90K |
| Net Property, Plant & Equipment | 1.70K | 6.60K | 12.90K | 17.80K | 22.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.79M | 54.00K | 29.20K | 29.10K | 2.00K |
| Total Assets | 22.53M | 78.50K | 63.60K | 72.40K | 37.30K |
|
|
|||||
| Total Accounts Payable | 1.12M | 1.22M | 1.24M | 1.21M | 1.19M |
| Total Accrued Expenses | 1.87M | 1.65M | 1.66M | 1.53M | 1.46M |
| Short-term Debt | 1.15M | 1.12M | 1.02M | 870.30K | 861.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.90K | 7.30K | 14.20K | 19.40K | 22.30K |
| Total Finance Division Other Current Liabilities | 191.80K | 159.10K | 165.10K | 163.60K | 157.40K |
| Total Other Current Liabilities | 191.80K | 159.10K | 165.10K | 163.60K | 157.40K |
| Total Current Liabilities | 4.34M | 4.16M | 4.10M | 3.79M | 3.69M |
|
|
|||||
| Total Current Liabilities | 4.34M | 4.16M | 4.10M | 3.79M | 3.69M |
| Long-Term Debt | 93.90K | 82.30K | 70.50K | 58.60K | 46.90K |
| Short-term Debt | 1.15M | 1.12M | 1.02M | 870.30K | 861.10K |
| Capital Leases | -- | -- | -- | -- | 1.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.44M | 4.24M | 4.17M | 3.85M | 3.74M |
|
|
|||||
| Common Stock & APIC | 138.22M | 61.88M | 61.82M | 61.70M | 61.35M |
| Retained Earnings | -121.55M | -67.48M | -67.05M | -66.70M | -66.34M |
| Treasury Stock & Other | 1.42M | 1.45M | 1.12M | 1.22M | 1.29M |
| Total Common Equity | 18.09M | -4.16M | -4.11M | -3.78M | -3.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.09M | -4.16M | -4.11M | -3.78M | -3.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.09M | -4.16M | -4.11M | -3.78M | -3.70M |
|
|
|||||